Share on:
In 2021, there have been 41 new drug approvals by the FDA. This means that novel treatment options are available for patients that may substantially improve the public health. From drugs that treat homozygous familial hypercholesterolemia to drugs that treat attention-deficit hyperactivity disorder (ADHD), the new drugs introduced to the market will likely have a profound impact on a wide range of diseases.
To be relevant practitioners, pharmacists and pharmacy technicians need to have a thorough understanding of the newly approved medications. The purpose of this knowledge-based activity is to educate pharmacists and pharmacy technicians on some of the recently approved drugs of 2021.
This is a knowledge-based continuing pharmacy education (CPE) activity is approved for 3 live contact hours (0.3 CEUs) and is appropriate for pharmacists and pharmacy technicians. To receive credit, participants must attend the entire session and complete program assessments.